by Spencer Aronfeld | Nov 9, 2015 | Defective Drugs, Defective Products, Low Testosterone
[youtube id="zG9zb8Dynco" align="center"] The multi-district litigation brought by men from around the country who have been injured taking low T drugs is now in front of Judge Matthew Kennely, who is a Clinton appointee. He has been on the Federal Bench in the Northern District of Illinois since 1999. This will be Judge Kennely’s first [Read More]
by Spencer Aronfeld | Oct 28, 2015 | Defective Drugs, Defective Products
The widely prescribed medications Benicar, Benicar HCT, Azor, and Tribenzor have been linked to serious gastrointestinal symptoms. All four drugs are used to treat high blood pressure and are actually made by the same company, Daiichi Sankyo, co-promoted by Forest Pharmaceuticals. Some of the common symptoms we have found reported include severe chronic diarrhea, dehydration, [Read More]
by Spencer Aronfeld | Oct 21, 2015 | Defective Drugs, Defective Products
Johnson and Johnson’s medication known as Invokana (canagliflozin) is currently being investigated by class-action lawyers from around the country in light of recently released reports indicating that people who are taking this drug are at increased risk for developing serious medical conditions, such as kidney failure, heart attacks, and strokes. Blood sugar is supposed to [Read More]
by Spencer Aronfeld | Mar 18, 2014 | Defective Drugs, Defective Products, Medical Malpractice
When it comes to potentially dangerous drugs--like testosterone replacement therapies—or cars, or even a light bulb, manufacturers always know more about the product’s risks than its consumer does. The law in our country that protects us from makers of those products--who put their profit ahead of the safety of people--is commonly referred to as strict [Read More]
by Spencer Aronfeld | Mar 11, 2014 | Defective Drugs, Low Testosterone
As an Androgel injury lawyer in Miami, I am concerned about the recent reports that men who take Androgel, Axiron, Testim, Foresta, and other low testosterone replacement drugs are at a higher risk for heart attacks and strokes. Our lawyers in Miami for people who want to sue a drug company believe the FDA should [Read More]
by Spencer Aronfeld | Mar 11, 2014 | Defective Drugs, Low Testosterone
Black Box warnings issued by the FDA are reserved for drugs that can cause problems leading to death or serious injury. In January, the FDA announced that it was investigating claims, in large part based upon reports of patients who have taken testosterone replacement drugs and then suffered heart attacks or strokes. In January the [Read More]
